Epidemiology of Surgical Site Infections With Staphylococcus aureus in Europe: Protocol for a Retrospective, Multicenter Study

Sibylle C Mellinghoff, Jörg Janne Vehreschild, Blasius J Liss, Oliver A Cornely, Sibylle C Mellinghoff, Jörg Janne Vehreschild, Blasius J Liss, Oliver A Cornely

Abstract

Background: Surgical site infections (SSIs) are among the most common hospital acquired infections. While the incidence of SSI in certain indicator procedures is the subject of ongoing surveillance efforts in hospitals and health care systems around the world, SSI rates vary markedly within surgical categories and are poorly represented by routinely monitored indicator procedures (eg, mastectomy or hernia surgery). Therefore, relying on indicator procedures to estimate the burden of SSI is imprecise and introduces bias as hospitals may take special precautions to achieve lower SSI rates. The most common cause of SSI is Staphylococcus aureus (S. aureus), as recently confirmed by a Europe-wide point-prevalence study conducted by the European Centre for Disease Prevention and Control (ECDC).

Objective: The primary objective of this study is to determine the overall and procedure-specific incidence of S. aureus SSI in Europe. Secondary objectives are the overall and procedure-specific outcomes as well as the economic burden of S. aureus SSI in Europe. Explorative objectives are to characterize the composition of the surgical patient population and to estimate the number of patients at risk for S. aureus SSI.

Methods: A retrospective, multinational, multicenter cohort study (Staphylococcus aureus Surgical Site Infection Multinational Epidemiology in Europe [SALT] study) with a nested case-control part will be conducted. The study will include all surgical procedures at a participating center in order to prevent selection bias and strengthen the understanding of SSI risk by determining the incidence for all common surgical procedures. Data will be assessed in the cohort population, including 150,000 adult patients who underwent any surgical procedure in 2016, and the case-control population. We will match patients establishing S. aureus SSI 1:1 with controls from the same center. Data on demographics, surgery, and microbiology will be exported from electronic files. More detailed data will be captured from the case-control population. The SALT study will include 13 major or academic surgical centers in Europe, comprising 3 in France, 4 in Germany, 2 in Italy, 3 in Spain, and 1 in the United Kingdom. Sites were selected using a feasibility questionnaire.

Results: The SALT study is currently recruiting patients. The aim is to complete recruitment in February 2018 and to close the database in September 2018. The final results are expected by the end of 2018.

Conclusions: Results of the SALT study will help to better understand the precise risk of certain procedures. They will also provide insight into the overall and procedure-specific incidence and outcome as well as the economic burden of S. aureus SSI in Europe. Findings of the study may help guide the design of clinical trials for S. aureus vaccines.

Trial registration: ClinicalTrials.gov NCT03353532; https://ichgcp.net/clinical-trials-registry/NCT03353532 (Archived by WebCite at http://www.webcitation.org/6xAK3gVmO).

Keywords: Staphylococcus aureus; cohort study; nested case-control; surgical site infection.

Conflict of interest statement

Conflicts of Interest: None declared.

©Sibylle C Mellinghoff, Jörg Janne Vehreschild, Blasius J Liss, Oliver A Cornely. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 12.03.2018.

Figures

Figure 1
Figure 1
Data assessment and matching procedure. ASA: American Society of Anesthesiologists; BMI: body mass index.
Figure 2
Figure 2
Study timelines. SAP: Statistical Analysis Plan; IRB: institutional review board; ECCMID:European Congress of Clinical Microbiology and Infectious Diseases; SSI: surgical site infections.

References

    1. European Centre for Disease Prevention and Control. 2012. Feb, [2018-01-02]. Surveillance of surgical site infections in European hospitals – HAISSI protocol. Version 1.02 .
    1. Collins A. Preventing health care–associated infections. In: Hughes R, editor. Patient Safety and Quality: An Evidence-Based Handbook for Nurses. Vol 2. Rockville: Paperback; 2008. pp. 547–575.
    1. Rosenthal VD, Richtmann R, Singh S, Apisarnthanarak A, Kübler A, Viet-Hung N, Ramírez-Wong FM, Portillo-Gallo JH, Toscani J, Gikas A, Dueñas L, El-Kholy A, Ghazal S, Fisher D, Mitrev Z, Gamar-Elanbya MO, Kanj SS, Arreza-Galapia Y, Leblebicioglu H, Hlinková S, Memon BA, Guanche-Garcell H, Gurskis V, Alvarez-Moreno C, Barkat A, Mejía N, Rojas-Bonilla M, Ristic G, Raka L, Yuet-Meng C, International Nosocomial Infection Control Consortiuma Surgical site infections, International Nosocomial Infection Control Consortium (INICC) report, data summary of 30 countries, 2005-2010. Infect Control Hosp Epidemiol. 2013 Jun;34(6):597–604. doi: 10.1086/670626.
    1. Saeed MJ, Dubberke ER, Fraser VJ, Olsen MA. Procedure-specific surgical site infection incidence varies widely within certain National Healthcare Safety Network surgery groups. Am J Infect Control. 2015 Jun;43(6):617–23. doi: 10.1016/j.ajic.2015.02.012.
    1. Zarb P, Coignard B, Griskeviciene J, Muller A, Vankerckhoven V, Weist K, Goossens M, Vaerenberg S, Hopkins S, Catry B, Monnet Dl, Goossens H, Suetens C, National Contact Points for the ECDC pilot point prevalence survey. Hospital Contact Points for the ECDC pilot point prevalence survey The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use. Euro Surveill. 2012 Nov 15;17(46)
    1. de Lissovoy G, Fraeman K, Hutchins V, Murphy D, Song D, Vaughn BB. Surgical site infection: incidence and impact on hospital utilization and treatment costs. Am J Infect Control. 2009 Jun;37(5):387–97. doi: 10.1016/j.ajic.2008.12.010.
    1. Coello R, Charlett A, Wilson J, Ward V, Pearson A, Borriello P. Adverse impact of surgical site infections in English hospitals. J Hosp Infect. 2005 Jun;60(2):93–103. doi: 10.1016/j.jhin.2004.10.019.
    1. Zimlichman E, Henderson D, Tamir O, Franz C, Song P, Yamin CK, Keohane C, Denham CR, Bates DW. Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med. 2013;173(22):2039–46. doi: 10.1001/jamainternmed.2013.9763.
    1. Boltz MM, Hollenbeak CS, Julian KG, Ortenzi G, Dillon PW. Hospital costs associated with surgical site infections in general and vascular surgery patients. Surgery. 2011 Nov;150(5):934–42. doi: 10.1016/j.surg.2011.04.006.
    1. Weber WP, Zwahlen M, Reck S, Feder-Mengus C, Misteli H, Rosenthal R, Brandenberger D, Oertli D, Widmer AF, Marti WR. Economic burden of surgical site infections at a European university hospital. Infect Control Hosp Epidemiol. 2008 Jul;29(7):623–9. doi: 10.1086/589331.
    1. Schweizer ML, Cullen JJ, Perencevich EN, Vaughan Sarrazin MS. Costs associated with surgical site infections in Veterans Affairs Hospitals. JAMA Surg. 2014 Jun;149(6):575–81. doi: 10.1001/jamasurg.2013.4663.
    1. Leaper DJ, van GH, Reilly J, Petrosillo N, Geiss HK, Torres AJ, Berger A. Surgical site infection - a European perspective of incidence and economic burden. Int Wound J. 2004 Dec;1(4):247–73. doi: 10.1111/j.1742-4801.2004.00067.x.
    1. Brandt C, Sohr D, Behnke M, Daschner F, Rüden H, Gastmeier P. Reduction of surgical site infection rates associated with active surveillance. Infect Control Hosp Epidemiol. 2006 Dec;27(12):1347–51. doi: 10.1086/509843.
    1. Urban JA. Cost analysis of surgical site infections. Surg Infect (Larchmt) 2006;7 Suppl 1:S19–22. doi: 10.1089/sur.2006.7.s1-19.
    1. Charlson ME, Pompei PP, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987 Jan;40(5):373–383. doi: 10.1016/0021-9681(87)90171-8.
    1. Leclère B, Lasserre C, Bourigault C, Juvin ME, Chaillet MP, Mauduit N, Caillon J, Hanf M, Lepelletier D, SSI Study Group Matching bacteriological and medico-administrative databases is efficient for a computer-enhanced surveillance of surgical site infections: retrospective analysis of 4,400 surgical procedures in a French university hospital. Infect Control Hosp Epidemiol. 2014 Nov;35(11):1330–5. doi: 10.1086/678422.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi